miRecule

miRecule, Inc. is an early-stage biotechnology company dedicated to developing RNA-based therapies. Our drug design approach focuses on using genomic patient data to create highly tailored treatments, ensuring the right drug for the right patient.miRecule's proprietary DREAmiR™ platform leverages genomic and outcome data from thousands of patients to identify the underlying genetic changes responsible for their diseases, then creates a novel RNA therapeutic that directly targets and repairs the genetic abnormality.miRecule is currently utilizing the DREAmiR™ platform to develop first-in-class therapies, with lead programs in head and neck cancer and muscular dystrophy.